Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 10, Number 9—September 2004

Research

Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002

Edine W. Tiemersma*Comments to Author , Stef L.A.M. Bronzwaer†, Outi Lyytikäinen†, John E. Degener‡, Paul Schrijnemakers*, Nienke Bruinsma*, Jos Monen*, Wolfgang Witte§, Hajo Grundmann*, and European Antimicrobial Resistance Surveillance System Participants
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands; †National Public Health Institute, Helsinki, Finland; ‡University Hospital Groningen, Groningen, the Netherlands; §Robert Koch Institute, Werningerode, Germany

Main Article

Figure 3

A) Variation in methicillin-resistant Staphylococcus aureus (MRSA) proportions between hospitals with AST results of >20 blood isolates, displayed by ranking of MRSA proportion (from lowest to highest). Only countries with more than one hospital are displayed. Hospital-specific proportions (open diamonds) are grouped per country. The solid horizontal bars represent the mean MRSA proportion per country. B) Local variation, showing the power-transformed variance being independent of the mean MR

Figure 3. A) Variation in methicillin-resistant Staphylococcus aureus (MRSA) proportions between hospitals with AST results of >20 blood isolates, displayed by ranking of MRSA proportion (from lowest to highest). Only countries with more than one hospital are displayed. Hospital-specific proportions (open diamonds) are grouped per country. The solid horizontal bars represent the mean MRSA proportion per country. B) Local variation, showing the power-transformed variance being independent of the mean MRSA proportion per country, displayed by ranking of MRSA proportion (from lowest to highest). Only hospitals reporting >20 isolates are included. Countries with less than five reporting hospitals are not shown (Iceland and Malta [1], Estonia [3], Bulgaria and Luxembourg [4]).

Main Article

1European Antimicrobial Resistance Surveillance System national representatives, 2002: Austria: H. Mittermayer, W. Koller; Belgium: H. Goossens, E. Hendrickx; Bulgaria: B. Markova; Croatia: S. Kalenic, A. Tambic-Andrasavic; Czech Republic: P. Urbaskova; Denmark: D. Monnet; Estonia: P. Naaber; Finland: O. Lyytikäinen, A. Nissinen; France: H. Aubry-Damon, P. Courvalin; Germany: U. Buchholz, W. Witte; Greece: N. Legakis, G. Vatopoulos; Hungary: M. Füzi; Ireland: D. O’Flanagan, O. Murphy; Iceland: K. Kristinsson; Israel: R. Raz; Italy: G. Cornaglia, P. D’Ancona; Luxembourg: R. Hemmer; Malta: M. Borg; Netherlands: A. de Neeling, E. Tiemersma; Norway: A. Hoiby, E. Bjørløw; Poland: W. Hryniewicz; Portugal: M. Caniça; Romania: I. Codita; Slovenia: M. Gubina, J. Kolman; Slovakia: L. Langsadl; Spain: F. Baquero, J. Campos; Sweden: B. Liljequist; United Kingdom: A. Johnson, M. Whale.

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO